bisbenzimidazole has been researched along with Lymphoma in 2 studies
Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.
Lymphoma: A general term for various neoplastic diseases of the lymphoid tissue.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Saiko, P | 1 |
Bauer, W | 1 |
Horvath, Z | 1 |
Hoechtl, T | 1 |
Grusch, M | 1 |
Illmer, C | 1 |
Madlener, S | 1 |
Krupitza, G | 1 |
Mader, RM | 1 |
Schott, H | 1 |
Fritzer-Szekeres, M | 1 |
Szekeres, T | 1 |
Arnold, B | 1 |
Battye, FL | 1 |
Miller, JF | 1 |
2 other studies available for bisbenzimidazole and Lymphoma
Article | Year |
---|---|
Cytotoxic and apoptotic effects of novel heterodinucleoside phosphates consisting of 5-fluorodeoxyuridine and Ara-C in human cancer cell lines.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Bisbenzimidazole; Cell Line, Tumor; Colonic Neoplasms; C | 2004 |
An improved method for selecting T-cell hybridomas by the fluorescence-activated cell sorter.
Topics: Animals; Antigens, Surface; Bisbenzimidazole; Cell Line; Cell Separation; DNA; Histocytochemistry; H | 1979 |